Replay available

Rapid Micro Biosystems, Inc. (RPID) Q3 2025 Earnings Call

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q3 2025 earnings conference call, held 2025-11-07. Replay captured from the company's public earnings webcast.

Fri, November 7, 2025 at 8:30 AMendedReplay
Rapid Micro Biosystems, Inc. (RPID) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Brendan Smith

Analyst, TD Cohen

Mike Bollier

Investor Relations

Sean Worches

Chief Financial Officer

Paul Knight

Analyst, KeyBank

Rob Spignesi

President and Chief Executive Officer

Thomas Flatton

Analyst, Lake Street Capital Markets

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Rapid Microbiosystems third quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your first speaker today, Mike Bollier of Investor Relations. Please go ahead. Good morning, and thank you for joining the Rapid Microbiosystems third quarter 2025 earnings call. Joining me on the call are Rob Spignesi, President and Chief Executive Officer, and Sean Worches, Chief Financial Officer. Earlier today, we issued a press release announcing our third quarter 2025 financial results. A copy of the release is available on the company's website at rapidmicrobio.com under Investors in the News and Events section. Before we begin, I'd like to remind you that many statements made during this call may be considered forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements, including but not limited to statements relating to Rapid Micro's financial condition, assumptions regarding future financial performance, anticipated future cash usage, statements relating to the company's term loan facility, guidance for 2025...

More from Rapid Micro Biosystems, Inc.